~20 spots leftby Mar 2026

Physical Activity Program for Breast Cancer

(MFT4 Trial)

Recruiting in Palo Alto (17 mi)
Overseen byBernardine M Pinto, PhD
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of South Carolina
No Placebo Group

Trial Summary

What is the purpose of this trial?This is a 3-month physical activity intervention aimed to increase moderate-intensity activity among previously inactive breast cancer survivors. Participants will be eligible if they are not currently active, and have recently been diagnosed with breast cancer. Upon eligibility, participants will be randomized into one of two groups. The intervention group will receive weekly guidance from a peer coach to increase their activity throughout the three month intervention. The control group will be encouraged to self-monitor their physical activity throughout the three month intervention. Both groups will receive a Fitbit. Peer coaches will be trained to deliver the physical activity program using a web-based platform; all calls will be virtual. Participants will be assessed before and after the intervention.

Eligibility Criteria

This trial is for breast cancer survivors diagnosed within the last 5 years, who are currently inactive. They should be able to walk unassisted, read and speak English, and have access to a smartphone with Bluetooth and internet. Participants must not engage in more than 30 minutes of vigorous or 90 minutes of moderate-intensity physical activity weekly.

Inclusion Criteria

I was diagnosed with Stage 0-3 breast cancer in the last 5 years.
Access to a smartphone with Bluetooth and internet
I can walk on my own without help.
+3 more

Participant Groups

The study tests if guidance from a peer coach can help increase moderate-intensity physical activity over three months compared to self-monitoring. Participants will be randomly placed into two groups: one receiving weekly virtual coaching and the other monitoring their own activity levels. Both groups get a Fitbit.
2Treatment groups
Experimental Treatment
Active Control
Group I: webMFTExperimental Treatment1 Intervention
Survivors randomized to webMFT will receive the evidence-based intervention for moderate-to-vigorous physical activity (MVPA) promotion that consists of MVPA counseling matched to patients' motivational readiness, and self-monitoring of MVPA (via Fitbit Inspire 2). The goal for the 3-month program will be to gradually increase the amount of moderate-intensity aerobic exercise that is performed, to the current national recommendations of at least 150 minutes of MPVA per week. Our goal is to promote aerobic exercise that is safe and enjoyable, such as walking.
Group II: MVPA trackingActive Control1 Intervention
These survivors will be asked to self-monitor moderate-to-vigorous physical activity (MVPA) participation by wearing the Fitbit Inspire 2 each day over 12 weeks. This group will not receive the MVPA counseling from the coaches.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of South CarolinaColumbia, SC
Loading ...

Who Is Running the Clinical Trial?

University of South CarolinaLead Sponsor
University of Colorado, DenverCollaborator
InquisitHealth, Inc.Collaborator
Brown UniversityCollaborator

References